Niklas Eskilsson is head of MAQS’ industry group for Life Science & Medtech. Niklas has extensive experience of the often-complicated agreements that companies in the life science sector must manage, such as research, development, licensing and collaboration agreements and the special regulations that apply to the area. Niklas regularly advise both early-phase development companies and mature companies with products on the market and actors on all levels, from manufacturers to distributors.

Visit MAQS Life science & Medtech to find out more.

Niklas also has extensive experience in advising clients in Swedish and international matters and  specializes in mergers and acquisitions, reinvestments, general corporate matters, and various commercial agreements.




MAQS Advokatbyrå, 2018-

Delphi Advokatbyrå, Partner, 2015-2018

Setterwalls Advokatbyrå, Associate, 2005-2015

AstraZeneca, Legal Counsel, 2002-2005

Stenungsund District Court, Law Clerk, 2000-2002


University of Gothenburg School of Business, Economics and Law, LL.M., 2000


Swedish Bar Association, 2007-

International Bar Association

Related news

MAQS has advised IRLAB Therapeutics AB in connection with admission to trading of the Company’s shares of series A on Nasdaq Stockholm Main Market

IRLAB Therapeutics AB (”IRLAB”) is a Swedish pharmaceutical research and development company that focuses on...
20.09.30 Read more

MAQS has advised in the sale of a majority stake in the language services company Plint

MAQS Advokatbyrå was the sellers’ legal adviser when Priveq acquired 55 percent of Plint AB. Priveq...
20.05.19 Read more